🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Paul Tudor Jones’s BIIB Holdings & Trades

First Buy
Q2 2013
Duration Held
47 Quarters
Largest Add
Q3 2016
+107,545 Shares
Current Position
26,088 Shares
$5.89 M Value

Paul Tudor Jones's BIIB Position Overview

Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 26,088 shares of Biogen Inc. (BIIB) worth $5.89 M, representing 0.01% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 47 quarters.

Based on 13F filings since 2013, Paul Tudor Jones has maintained a long-term strategic position in BIIB, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2016, adding 107,545 shares. Largest reduction occurred in Q4 2016, reducing 117,853 shares.

Analysis based on 13F filings available since 2013 Q2

Paul Tudor Jones's Biogen (BIIB) Holding Value Over Time

Track share changes against reported price movement

Quarterly Biogen (BIIB) Trades by Paul Tudor Jones

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +26,088 New Buy 26,088 $225.88
Q3 2025 -6,000 Sold Out 0 $0.00
Q2 2025 -99,851 Reduce 94.33% 6,000 $125.59
Q1 2025 +83,848 Add 381.08% 105,851 $136.84
Q4 2024 -31,708 Reduce 59.03% 22,003 $152.92
Q3 2024 +45,043 Add 519.65% 53,711 $193.84
Q2 2024 -36,374 Reduce 80.76% 8,668 $231.82
Q1 2024 +45,042 New Buy 45,042 $215.63
Q1 2023 -4,995 Sold Out 0 $0.00
Q4 2022 -4,548 Reduce 47.66% 4,995 $0.28
Q3 2022 +7,810 Add 450.66% 9,543 $267.00
Q2 2022 -3,259 Reduce 65.28% 1,733 $203.69
Q1 2022 +4,992 New Buy 4,992 $210.54
Q4 2021 -8,595 Sold Out 0 $0.00
Q3 2021 +4,606 Add 115.47% 8,595 $282.96
Q2 2021 +3,989 New Buy 3,989 $346.20
Q1 2021 -3,438 Sold Out 0 $0.00
Q4 2020 +3,438 New Buy 3,438 $244.91
Q3 2020 -4,820 Sold Out 0 $0.00
Q2 2020 +482 Add 11.11% 4,820 $267.63
Q1 2020 +590 Add 15.74% 4,338 $316.27
Q4 2019 -48,931 Reduce 92.89% 3,748 $296.69
Q3 2019 +19,242 Add 57.55% 52,679 $232.83
Q2 2019 -6,874 Reduce 17.05% 33,437 $233.87
Q1 2019 +15,601 Add 63.14% 40,311 $236.39
Q4 2018 +6,248 Add 33.84% 24,710 $300.93
Q3 2018 +10,871 Add 143.21% 18,462 $353.32
Q2 2018 +1,953 Add 34.64% 7,591 $290.21
Q1 2018 +2,284 Add 68.10% 5,638 $273.86
Q4 2017 +3,354 New Buy 3,354 $318.43
Q2 2017 -1,752 Sold Out 0 $0.00
Q1 2017 -6,063 Reduce 77.58% 1,752 $273.40
Q4 2016 -117,853 Reduce 93.78% 7,815 $283.56
Q3 2016 +107,545 Add 593.42% 125,668 $313.03
Q2 2016 +17,123 Add 1712.30% 18,123 $241.85
Q1 2016 -3,368 Reduce 77.11% 1,000 $260.00
Q4 2015 +4,368 New Buy 4,368 $306.32
Q3 2015 -600 Sold Out 0 $0.00
Q2 2015 -4,280 Reduce 87.70% 600 $403.33
Q1 2015 -22,906 Reduce 82.44% 4,880 $422.34
Q4 2014 +24,725 Add 807.74% 27,786 $339.45
Q3 2014 +2,162 Add 240.49% 3,061 $330.94
Q2 2014 -2,400 Reduce 72.75% 899 $314.79
Q1 2014 +1,532 Add 86.70% 3,299 $305.85
Q4 2013 +267 Add 17.80% 1,767 $279.57
Q3 2013 -2,300 Reduce 60.53% 1,500 $240.67
Q2 2013 +3,800 Add 0.00% 3,800 $215.26

Paul Tudor Jones's Biogen Investment FAQs

Paul Tudor Jones first purchased Biogen Inc. (BIIB) in Q2 2013, acquiring 3,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Paul Tudor Jones has held Biogen Inc. (BIIB) for 47 quarters since Q2 2013.

Paul Tudor Jones's largest addition to Biogen Inc. (BIIB) was in Q3 2016, adding 125,668 shares worth $39.34 M.

According to the latest 13F filing for Q3 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 26,088 shares of Biogen Inc. (BIIB), valued at approximately $5.89 M.

As of the Q3 2026 filing, Biogen Inc. (BIIB) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.

Paul Tudor Jones's peak holding in Biogen Inc. (BIIB) was 125,668 shares, as reported at the end of Q3 2016.